Premier Research Names Etienne Drouet Executive Director, Oncology Europe
“Etienne brings a tremendous amount of operational knowledge and oncology acumen serving the needs of our customers,” said Dr. Sue Stansfield, Executive VP, Clinical Development. Dr. Ludo Reynders added, “Having worked with Etienne before, I am pleased to have someone of his caliber lead our European oncology team.”
Mr. Drouet offers practical insight to oncology clinical trials with more than 19 years in drug development including 14 years in clinical research and five years as a research scientist. Mr. Drouet has held positions of increasing responsibility at pharmaceutical, contract research, and investigational cooperative groups including Rhône Poulenc Rorer (Sanofi Aventis), Icon, and Breast Cancer International Research Group. His extensive oncology experience and expertise has ensured timely, efficient program delivery. He holds a Biotechnology Engineering degree from the European Engineering School of Biotechnology and a Master in Science degree from the University Louis Pasteur.
About Premier Research
Premier Research is a professional services company providing clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide. The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it provides a strong strategic sourcing group that supports customers in their resource planning and management.
The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.
For more information please visit, www.premier-research.com.
For further information, please contact:
Tel: +1 215 282 5391